Aptevo Therapeutics Inc
(APVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 3,114 | 12,292 | 4,309 |
| Gross Profit | N/A | N/A | 3,114 | 12,292 | 4,309 |
| Operating Expenses | 24,602 | 28,878 | 31,755 | 33,692 | 31,803 |
| Operating Income | -24,602 | -28,878 | -28,641 | -21,400 | -27,494 |
| Other Income | 472 | 10,228 | 35,655 | -8,008 | -3,429 |
| Pre-tax Income | -24,130 | -18,650 | 7,014 | -29,408 | -30,923 |
| Net Income Continuous | -24,130 | -18,650 | 7,014 | -29,408 | -30,923 |
| Net Income Discontinuous | N/A | 1,239 | 1,013 | 951 | 13,173 |
| Net Income | $-24,130 | $-17,411 | $8,027 | $-28,457 | $-17,750 |
| EPS Basic Total Ops | -31,431.65 | -833,392.10 | 1.57 | -6.07 | -5.23 |
| EPS Basic Continuous Ops | -31,433.15 | -892,699.00 | 1.38 | -6.27 | -9.12 |
| EPS Basic Discontinuous Ops | N/A | 59,305.85 | 0.20 | 0.20 | 3.88 |
| EPS Diluted Total Ops | -31,431.65 | -833,392.10 | 1.57 | -6.07 | -5.23 |
| EPS Diluted Continuous Ops | -31,433.15 | -892,699.00 | 1.37 | -6.27 | -9.12 |
| EPS Diluted Discontinuous Ops | N/A | 59,305.85 | 0.20 | 0.20 | 3.88 |
| EPS Diluted Before Non-Recurring Items | -31,431.65 | -872,697.81 | N/A | N/A | N/A |
| EBITDA(a) | $-24,250 | $-28,311 | $-27,740 | $-20,256 | $-26,088 |